Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS
Phase 1
Not yet recruiting
- Conditions
- COVID-19Acute Respiratory Distress SyndromeARDS
- Interventions
- Biological: Human umbilical cord mesenchymal stem cells + best supportive careOther: Placebo control + best supportive care
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Baylx Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT04452097
Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis
Phase 1
Not yet recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: PlaceboBiological: hUC-MSC suspension
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Baylx Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03828344
News
No news found